The inside story of the race to develop Ozempic, and its potentially revolutionary impact on public health and culture.
One in eight American adults--over 15 million people--has recently started using Ozempic or another semaglutide medication.
Author Aimee Donnellan is a veteran Reuters journalist and her book is rooted in extensive research and interviews with dozens of people involved with Ozempic, from the scientists that first discovered the drug to beauty and pharmaceutical industry executives to Dr. Oz.
From The Emperor of All Maladies to The Immortal Life of Henrietta Lacks, readers flock to books about widespread medical issues and breakthroughs in treating them. Off the Scales is the first book to tell the story of Ozempic, offering a never-before-seen look at how Ozempic was discovered and the outsized impact it promises to have on modern life.